Performance of Endobronchial Ultrasound Transbronchial Needle Aspiration (EBUS-TBNA) with Rapid On-Site Evaluation (ROSE) in the pathological subtyping and molecular testing of non-small cell lung cancer (NSCLC) at a UK institute

Conclusions: Our study has illustrated EBUS-TBNA cytology with ROSE can achieve accurate subtyping of NSCLC and a high proportion of sufficient material for molecular analysis. In addition our NSCLC-NOS rate (8.6%)is lower than UK national average (9%) in 2017.References: 1- Royal College of Physicians. National Lung Cancer Audit annual report 2017

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Craig, C., Bailey, S., Narine, N., Shelton, D., Thiryayi, S., Rana, D., Al-Najjar, H. Tags: Interventional Pulmonology Source Type: research